1. Introduction {#sec0005}
===============

Small bowel as initial site of distant metastasis is relatively rare clinical entity, and mostly has been reported with colon, uterus, cervix, ovaries, and breast malignancies [@bib0005]. Distant metastases from lung cancer are usually found in the adrenal glands, bone, liver, and brain; however, metastasis in the small bowel is extremely uncommon [@bib0010]. Among small bowel metastasis, the jejunum is the most frequent site of involvement (50.9%), followed by the ileum (33.3%), and the duodenum (15.8%) [@bib0015]. Duodenal metastases rarely show any symptoms; however, duodenal involvement of lung cancer can elicit melena, hypochromic microcytic anemia, upper gastrointestinal (GI) bleeding, malabsorption, intussusception and obstruction [@bib0020; @bib0025].

Herein we report our experience with a case of melena and weight loss secondary to metastatic lung adenocarcinoma at the time of presentation.

2. Presentation of case {#sec0010}
=======================

A 52-year-old Syrian male patient presented with the six months history of epigastric pain and melena. He also complained of anorexia, lethargy, and weight loss of 4 kilograms over past four months. Epigastric pain was dull in nature, aggravated by food intake, and it had increased in intensity over two weeks, for which he was taking oxycodone/acetaminophen, but minimal pain relief. His previous medical and surgical history was unremarkable. He was active smoker with one pack a day for 15 years; however, he denied any alcohol consumption.

On physical examination, he was found in good general condition, and his vitals were stable. On abdominal examination, there was mild epigastric tenderness without any rigidity, guarding, or rebound tenderness. The rest of systemic examination was unremarkable.

Complete blood count (CBC) showed hemoglobin (Hb) 8.4 gm/dl ↓; mean corpuscular volume (MCV) 75 femtoliters (fL) ↓; mean corpuscular hemoglobin (MCH) 24 picograms (pg)↓, white blood cells (WBC) 7400/μl; red blood cells (RBCs) 4 × 10^6^/μl; and platelets 356.000/μl. Liver and renal function tests were within normal limits. Fecal occult blood (FOB) test was found positive. Two units of packed RBCs were transfused to the patient before elective esophago-gastroduodenoscopy and colonoscopy. Esophago-gastroduodenoscopy revealed a 10 mm ulcerative lesion in the fourth part of duodenum with no bleeding, which was resected with cold forceps ([Fig. 1](#fig0005){ref-type="fig"}). The examination of esophagus, stomach and gastroesophageal junction appeared normal, and colonoscopy was also unremarkable. Histopathology of resected duodenal lesion showed duodenal mucosal ulceration beneath of which there was subepithelial tumor infiltration, and necrosis. The neoplasm had nests, cords and single cell growth pattern in addition to glandular formations. Tumor cells were polygonal shaped with high nuclear/cytoplasmic ratio. There was also marked nuclear pleomorphism and frequent mitoses ([Fig. 2](#fig0010){ref-type="fig"}). The overall picture was that of poorly differentiated adenocarcinoma. Immunohistochemical analysis showed that the tumour was positive for cytokeratin-7 (CK7), thyroid transcription factor 1 (TTF-1), and negative for CK20, Villin, CDX2 and thyroglobulin ([Fig. 3](#fig0015){ref-type="fig"}). These findings strongly supported the diagnosis of metastatic adenocarcinoma of the lung origin.

Computed tomography (CT) of chest showed ill-defined necrotic mass measuring 4 × 3.2 cm in left hilar region involving and extending to the anterior segment of left upper lobe. The mass was encasing the left main pulmonary artery, alongwith ipsilateral hilar and contra-lateral para-tracheal, peri-carinal, sub-carinal and hilar lymph nodes ([Fig. 4](#fig0020){ref-type="fig"}A). CT abdomen was unremarkable. CT-positron emission tomography (CT-PET) showed ^18^flouro-deoxyglucose (FDG) avid left upper lobe elongated lung mass \[standardized uptake volume (SUV~max~) 9.3\] extending from the left hilum to the pleural surface in the left apical region. There were also FDG avid right upper paratracheal (SUV~max~ 4.9), left hilar (SUV~max~ 4.7), and subcarinal (SUV~max~ 6.6) lymph nodes ([Fig. 4](#fig0020){ref-type="fig"}B). The rest of staging work up was negative. Bronchoscopy assisted biopsy of lung lesion confirmed the diagnosis of primary adenocarcinoma with negative epidermal growth factor receptor mutation (EGFR-). Patient was staged as T4N3M1.

After discussing the case in a multidisciplinary tumor board meeting, patient was started on cisplatinum based chemotherapy with Bevacizumab. After three cycles of chemotherapy, melena resolved completely; however, he developed multiple brain metastases. After the completion of whole brain radiation therapy, he was started on oral continuous daily dose of 150 mg Erlotinib.

3. Discussion {#sec0015}
=============

Duodenal involvement as delayed site of distant metastasis or as initial manifestation of primary lung carcinoma is extremely rare. Signs and symptoms depend on the anatomic site of duodenal involvement [Table 1](#tbl0005){ref-type="table"} [@bib0030; @bib0035; @bib0040; @bib0045; @bib0050; @bib0055; @bib0060; @bib0065; @bib0070; @bib0075; @bib0080].

Duodenal metastasis poses a diagnostic dilemma, as radiologic imaging is often unremarkable as seen our patient. Endoscopic evaluation and biopsy should be performed in such cases to establish a definitive diagnosis especially if the cause of melena or microcytic anemia cannot be ascertained [@bib0030]. Endoscopic ultrasonography (EUS) may be helpful for localization of submuscoal duodenal metastasis in some cases [@bib0025; @bib0030; @bib0035].

The treatment of duodenal metastasis is also challenging, and it depends on the site of duodenal involvement and size of these lesions. However, most of cases require duodenectomy or pancreatico-duodenectomy for symptomatic relief [@bib0030; @bib0035; @bib0040; @bib0045; @bib0050]. Endoscopic resection of smaller duodenal metastatic lesions (≤1 cm) appears to be safe and effective, especially in cases in which these metastases may be removed completely by endoscopic methods, as seen in our patient [@bib0055; @bib0060; @bib0065; @bib0070; @bib0075]. The role of radiation therapy needs to be investigated, as only case report utilizing radiation therapy for duodenal metastasis has been reported [@bib0080].

Duodenal metastasis is associated with dismal prognosis. Only a few cases have survived more than 12 months after surgical resection of duodenal metastases, with the exception of one patient who survived 46 months [@bib0045].

In conclusion, duodenal metastasis from lung adenocarcinoma is extremely rare entity and should also be included in the differential diagnosis of melena. Smaller lesions (≤1 cm) can safely be managed with endoscopic resection.
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![Esophagastroduodenoscopy showing an ulcerative lesion in the fourth part of duodenum with no active bleeding.](gr1){#fig0005}

![Biopsy of duodenal lesion showing neoplasm forming glandular and cords pattern with frequent mitoses (H & E stain, 400 × magnifications).](gr2){#fig0010}

![Biopsied duodenal lesion showing CK7 immunopositive tumor cells (CK7 immunostain, 400 × magnifications) suggesting metastatic adenocarcinoma of lung origin.](gr3){#fig0015}

![(A) axial view of computed tomography chest showing left hilar mass encasing the left main pulmonary artery and causing narrowing of left upper lobe bronchus, and (B) CT-PET imaging showing ^18^FDG avid left upper lobe elongated lung mass (standardized uptake volume 9.3) extending from the left hilum to the pleural surface in the left apical region.](gr4){#fig0020}

###### 

Previously published case reports of duodenal metastasis from primary lung carcinoma.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference    Age (years)/sex   Symptoms                                     Time of diagnosis                                   Location                            Histopathology            Treatment                                           Follow-up   Status
  ------------ ----------------- -------------------------------------------- --------------------------------------------------- ----------------------------------- ------------------------- --------------------------------------------------- ----------- -------------------------------
  [@bib0080]   63/M              Melena, microcytic anemia                    24 months after treatment for primary lung cancer   3rd part of duodenum                Squamous cell carcinoma   Duodenectomy                                        5 months    Dead with progressive disease

  [@bib0060]   66/M              Perforation                                  During chemoradiation for primary lung cancer       4th part of duodenum                Squamous cell carcinoma   Duodenectomy followed by chemotherapy               --          --

  [@bib0070]   75/M              Melena, microcytic anemia, intussusception   At time of diagnosis of primary lung cancer         2nd and 3rd parts of duodenum       Small cell carcinoma      Pancreaticoduodenectomy                             --          --

  [@bib0030]   58/M              Obstruction                                  2 years after treatment for primary lung cancer     2nd part of duodenum                Large cell carcinoma      Pancreatico-duodenectomy followed by chemotherapy   46 months   Alive disease free

  [@bib0035]   46/F              Melena, microcytic anemia                    20 days after treatment for primary lung cancer     4th part of duodenum                Large cell carcinoma      Duodenectomy followed by chemotherapy               12 months   Dead\
                                                                                                                                                                                                                                                                Brain metastasis

  [@bib0040]   61/M              Melena, weight loss, hemoptysis              At time of diagnosis of primary lung cancer         4th part of duodenum                Adenocarcinoma            Endoscopic resection, Chemotherapy\                 7 months    Dead\
                                                                                                                                                                                                Blood transfusion, Erythropoietin                               Progressive lung disease

  [@bib0045]   55/M              Upper GI bleeding                            --                                                  3rd part of duodenum invading SMA   Adenocarcinoma            --                                                  Few days    Dead\
                                                                                                                                                                                                                                                                Massive GI bleeding

  [@bib0050]   66/M              Upper GI bleeding                            8 months after treatment for primary lung cancer    --                                  Adenocarcinoma            --                                                  Few weeks   Dead with massive GI bleeding

  [@bib0055]   65/M              Jaundice, obstruction                        --                                                  2nd part of duodenum                Squamous cell carcinoma   Endoscopic resection                                --          --

  [@bib0065]   54/M              Dysphagia                                    During chemoradiation for primary lung cancer       1st and 2nd parts of duodenum       Squamous cell carcinoma   Endoscopic resection                                2 months    Dead

  [@bib0075]   69/M              Incidental on imaging                        36 months after treatment for primary lung cancer   2nd part of duodenum                Small cell carcinoma      Palliative RT 30Gy in 10 fractions                  --          --
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

M = male, F = female, SMA = superior mesenteric artery, GI = gastrointestinal, RT = radiation therapy
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